Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol
The Effect of a Circuit Resistance Training, Empagliflozin or Vegeterranean Diet on Physical and Metabolic Function in Elderly Subjects With Type 2 Diabetes: a Study Protocol for a Randomized Control Trial (CEV-65 Trial)
Sponsor: Tel-Aviv Sourasky Medical Center
Listed as NCT03560375, this PHASE4 trial focuses on Diabetes Mellitus, Type 2 and Sarcopenia and remains completed. Sponsored by Tel-Aviv Sourasky Medical Center, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed
-
Sep 2024 — Oct 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Jul 2018 — Dec 2020 [monthly]
Recruiting PHASE4
First recorded
May 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tel-Aviv Sourasky Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .